JP2008507543A5 - - Google Patents

Download PDF

Info

Publication number
JP2008507543A5
JP2008507543A5 JP2007522737A JP2007522737A JP2008507543A5 JP 2008507543 A5 JP2008507543 A5 JP 2008507543A5 JP 2007522737 A JP2007522737 A JP 2007522737A JP 2007522737 A JP2007522737 A JP 2007522737A JP 2008507543 A5 JP2008507543 A5 JP 2008507543A5
Authority
JP
Japan
Prior art keywords
alkyl
independently
hydrogen
hydroxy
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007522737A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008507543A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/025843 external-priority patent/WO2006012396A1/en
Publication of JP2008507543A publication Critical patent/JP2008507543A/ja
Publication of JP2008507543A5 publication Critical patent/JP2008507543A5/ja
Pending legal-status Critical Current

Links

JP2007522737A 2004-07-22 2005-07-21 抗細菌剤 Pending JP2008507543A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59017404P 2004-07-22 2004-07-22
PCT/US2005/025843 WO2006012396A1 (en) 2004-07-22 2005-07-21 Antibacterial agents

Publications (2)

Publication Number Publication Date
JP2008507543A JP2008507543A (ja) 2008-03-13
JP2008507543A5 true JP2008507543A5 (enExample) 2008-09-04

Family

ID=35786535

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007522737A Pending JP2008507543A (ja) 2004-07-22 2005-07-21 抗細菌剤

Country Status (4)

Country Link
US (1) US20070270417A1 (enExample)
EP (1) EP1778688A1 (enExample)
JP (1) JP2008507543A (enExample)
WO (1) WO2006012396A1 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4887297B2 (ja) * 2004-09-24 2012-02-29 アクテリオン ファーマシューティカルズ リミテッド 新規二環式抗生物質
JP2008528586A (ja) 2005-01-25 2008-07-31 グラクソ グループ リミテッド 抗菌剤
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
US7709496B2 (en) 2006-04-06 2010-05-04 Glaxo Group Limited Antibacterial agents
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
MX2008014908A (es) * 2006-05-26 2009-05-13 Toyama Chemical Co Ltd Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo.
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
CN101230058A (zh) * 2007-01-23 2008-07-30 上海恒瑞医药有限公司 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
PT2137196E (pt) 2007-04-20 2010-12-16 Glaxo Group Ltd Compostos tricíclicos contendo azoto como agentes antibacterianos
CA2689102C (en) * 2007-06-15 2016-07-26 Actelion Pharmaceuticals Ltd 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
RU2487866C2 (ru) * 2008-01-23 2013-07-20 Цзянсу Хэнсох Фармасьютикал Ко., Лтд. Производные дициклоазаалкана, способы их получения и их применение в медицине
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
CN102292319A (zh) 2008-11-26 2011-12-21 雅培制药有限公司 作为钙通道阻滞剂的取代八氢环戊二烯并(c)吡咯-4-胺
US8318940B2 (en) 2009-01-15 2012-11-27 Glaxo Group Limited Naphthyridin-2 (1 H)-one compounds useful as antibacterials
ME03452B (me) 2009-10-23 2020-01-20 Janssen Pharmaceutica Nv Disupstituisani oktahi-dropirolo[3,4-c]piroli kao modulatori oreksin receptora
WO2011149993A2 (en) 2010-05-25 2011-12-01 Abbott Laboratories SUBSTITUTED OCTAHYDROCYCLOPENTA[c]PYRROLES AS CALCIUM CHANNEL MODULATORS
WO2011149995A1 (en) 2010-05-25 2011-12-01 Abbott Laboratories Novel substituted octahydrocyclopenta [c]pyrrol-4-amines as calcium channel blockers
JP6075736B2 (ja) * 2011-12-21 2017-02-08 ジエンス ヘンルイ メデイシンカンパニー リミテッドJiangsu Hengrui Medicine Co.,Ltd. ピロール−6員ヘテロアリール環誘導体、その合成法およびその医薬用途
US8822460B2 (en) 2012-04-06 2014-09-02 Janssen Pharmaceutica Nv Fused cyclopentyl antagonists of CCR2
ES2627010T3 (es) 2012-07-19 2017-07-26 Janssen Pharmaceutica, N.V. Antagonistas de octahidro-ciclopentapirrolilo de CCR2
CN102838609B (zh) * 2012-08-27 2014-12-24 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物及其制备方法和应用
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
AR101674A1 (es) 2014-08-22 2017-01-04 Glaxosmithkline Ip Dev Ltd Uso de un compuesto tricíclico que contiene nitrógeno
JO3579B1 (ar) 2014-09-26 2020-07-05 Luc Therapeutics Inc مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
KR20230116948A (ko) 2016-03-10 2023-08-04 얀센 파마슈티카 엔.브이. 오렉신-2 수용체 길항제를 사용한 우울증의 치료 방법
AR121715A1 (es) 2020-04-03 2022-06-29 Biocryst Pharm Inc Pirrolopirimidinaminas como inhibidores del sistema del complemento
US20250214980A1 (en) 2022-03-14 2025-07-03 Slap Pharmaceuticals Llc Multicyclic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1452619A (zh) * 2000-07-26 2003-10-29 史密斯克莱·比奇曼公司 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物

Similar Documents

Publication Publication Date Title
JP2008506695A5 (enExample)
JP2008505926A5 (enExample)
JP2005538125A5 (enExample)
JP2009532504A5 (enExample)
JP2008505920A5 (enExample)
JP2005519922A5 (enExample)
KR101542516B1 (ko) 5,6-다이하이드로-1h-파이리딘-2-온 화합물
JP2005527472A5 (enExample)
JP2008502689A5 (enExample)
JP2005504747A5 (enExample)
RU2007147413A (ru) Аминопиперидинхинолины и их азаизостерические аналоги с антибактериальной активностью
WO2006046039A3 (en) Tetracyclic indole derivatives as antiviral agents
AR049126A1 (es) Derivados de 5, 6, 7, 8 - tetrahidroimidazo[1,5a]piridina con actividad inhibitoria de la aldosterona sintasa, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos para el tratamiento del hiperaldosterismo y del sindrome de cushing.
PE20030431A1 (es) DERIVADOS QUINUCLIDINAS COMO AGONISTAS DEL RECEPTOR NICOTINICO DE LA ACETILCOLINA TIPO a7
AR048241A1 (es) Compuestos azufrados como inhibidores de la serina proteasa ns3 del virus de la hepatitis c .
AR048023A1 (es) Cetoamidas con p4 ciclicos como inhibidores de ns3 serina proteasa del virus de hepatitis c
JP2008509222A5 (enExample)
JP2006505505A5 (enExample)
JP2005525324A5 (enExample)
AR048413A1 (es) Compuestos prolina 3,4- (ciclopentil) - fusionados , como inhibidores de serina proteasa ns3 del virus de la hepatitis c
JP2008508359A5 (enExample)
JP2008526999A5 (enExample)
JP2005539087A5 (enExample)
JP2008507543A (ja) 抗細菌剤
HRP20140151T1 (hr) Derivati spiro-indola za lijeäśenje parazitnih bolesti